Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
Approved for use in oncology care according to FDA-approved indications.
Targeted treatment of solid tumors and hematologic malignancies.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Approved for use in oncology care according to FDA-approved indications.
Prevention and management of chemotherapy-related organ toxicities and complications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Approved for use in oncology care according to FDA-approved indications.